In this study, we demonstrated increased activation of JNK, as well as of its upstream regulator MKK7 in liver tissues from NAFLD mice which could be markedly reduced by TNFR1 inhibition. The gene discussed is MAP2K7; the disease is metabolic dysfunction-associated steatotic liver disease.